Researchers have identified the genetic risk factors that contribute to prostate cancer in a diverse group of African men.

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was ...

In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...

The overall survival data from the late-stage trial will help Pfizer in its bid to expand the label for Talzenna and Xtandi, ...

Pfizer’s Talzenna-Xtandi combination has marked a major step forward in treating advanced prostate cancer, improving patient ...

The following is a summary of “Characteristics of lymphoedema, in particular midline lymphoedema, after treatment for ...

Pfizer said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of ...

Former Portsmouth goalkeeper Alan Knight has revealed he has advanced prostate cancer. The 61-year spent 22 years at Fratton Park, making 801 appearances between 1978 and 2000 – the record for a ...

Tom Nolan reviews this week’s research Prostate cancer screening may be less controversial if we could reduce overdiagnosis of low risk disease. A new study suggests that magnetic resonance imaging ...

There's a small but significant increased of certain cancers in people battling multiple sclerosis (MS), new resear ...

The 76-year-old was receiving palliative care when he died in hospital in 2022, a month after a fall in a cell at HMP ...